-
A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy
Sep 9, 2025, 16:22 PM -
From Complex Statistics to Clinically Meaningful Insights: Interpreting Results in Meta-Analyses of Continuous Outcomes
Sep 9, 2025, 16:22 PM -
Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sep 9, 2025, 16:22 PM -
Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements
Sep 9, 2025, 16:22 PM -
Identifying CKD As a Key Driver of CVD Deaths
Sep 9, 2025, 16:22 PM -
Utilization of Best-Value Medicines for Teriparatide in the Irish Healthcare Setting
Sep 9, 2025, 16:22 PM -
Clinical and Economic Characteristics of eGFR-Mutated NSCLC Patients Treated With TKIs in South Korea: A Retrospective Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
Trends in the Number of Hospital Beds and Patient Turnover in Obstetrics and Gynecology in Hungary Between 2003 and 2023
Sep 9, 2025, 16:22 PM -
Burden of In-Clinic and At-Home Administration of Injectable Biologics for Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Interim Results From a Time and Motion Study
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of First-Line Therapies for Microsatellite-Instability-High (MSI-H) or Mismatch-Repair-Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (mCRC) in France
Sep 9, 2025, 16:22 PM -
Associations Between Waiting Time and Treatment Completion Among Treatment-Naive Pregnant Cannabis Users Admitted to Treatment Facilities in the United States
Sep 9, 2025, 16:22 PM -
Natural Language Processing for Identification of Negative Symptoms in Patients With and Without Cognitive Impairment Associated With Schizophrenia (CIAS)
Sep 9, 2025, 16:22 PM -
Projected Public Health Impact of Synchronized COVID-19 and Influenza Vaccination With a Combination Vaccine in US Older Adults
Sep 9, 2025, 16:22 PM -
Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada
Sep 9, 2025, 16:22 PM -
Evolution of National Price Negotiations for Pharmacy/Retail Medicines (Triparty Negotiations) in Sweden and Implications for Access
Sep 9, 2025, 16:22 PM -
Country-Specific Adaptation of Health Economic Models With Generative AI: A Case Study in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Economic Evaluation Studies for Schizophrenia
Sep 9, 2025, 16:22 PM -
Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison of Obecabtagene Autoleucel vs. Blinatumomab Inotuzumab Ozogamicin and Ponatinib in Relapsed or Refractory Adult B-cell Acute Lymphoblastic Leukemia
Sep 9, 2025, 16:22 PM
